2
Views
0
CrossRef citations to date
0
Altmetric
Session II: Clinical Physiology and Pharmacology

Contrasting Effects of the Renin–Angiotensin System on Renal Function Disclosed During Converting Enzyme Inhibition in Patients with Renal Hypertension

, &
Pages 49-52 | Published online: 27 Oct 2016

References

  • Aurell M., Delin K., Herlitz H. Captopril in treatment restant essential and renal hypertension. Scand. J. Urol. Nephrol. 16:243–9, 1982.
  • Bengis R.G., Coleman T.G. Antihypertensive effect of prolonged blockade of angiotensin formation in benign and malignant, one- and two-kidney Goldblatt hypertensive rats. Clin. Sci. 57:53–62, 1979.
  • Brown J.J., Casals-Stenzel J., dimming A.M.M., Davies D.L., Fraser R., Lever A.E., Morton J.J., Semple P.F., Tree M., Robertson J.I.S. Angiotensin II, aldosterone and arterial pressure: A quantitative approach. Hypertension, 1:159–79, 1979.
  • Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand. J. Clin. Lab. Invest. 30:271–4, 1972.
  • Curtis J.J., Luke R.G., Whelchel J.D., Diethelm A.G., Jones P., Dustan H. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N. Engl. J. Med. 308:377–81, 1983.
  • Dzau V.J., Siwek L.G., Rosen S., Farhi E.R., Mizoguchi H., Barger A.C Sequential renal hemodynamics in experimental benign and malignant hypertension. Hypertension 3(suppl I): 1.63–1.68, 1981.
  • Giese J., Damkjær Nielsen M., Kappelgaard A.M. Concentrations of active and inactive renin in human plasma concepts and methodology. In: Sambhi MP, ed. Heterogeneity of renin and renin-substrate. Elsevier North Holland, 205–13, 1981.
  • Hall J.E., Guyton A.C, Jackson T.E., Coleman T.G., Loh-meier T.E., Trippodo N.C. Control of glomerular filtration rate by renin-angiotensin system. Am. J. Physiol. 233: F-366-F372, 1977.
  • Hall J.E., Coleman T.G., Guyton A.C., Balfe J.W., Salgado H.C. Intrarenal role of angiotensin II and (des-Asp1) angiotensin II. Am. J. Physiol. 236:F252-F259, 1979.
  • Havelka J., Vetter H., Studer A., Greminger P., Lüscher T., Wollnik S., Siegenthaler W., Vetter W. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension, Am. J. Cardiol. 49:1467–74, 1982.
  • Hollenberg N.K., Meggs L.G., Williams G.H., Katz J., Garnic J.D., Harrington D.P. Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int. 20:240–5, 1981.
  • Hricik D.E., Browning P.J., Kopelman R., Goorno W.E., Madias N.E., Dzau V.J. Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenosis or renal-artery stenosis in a solitary kidney. N. Engl. J. Med. 308:373–6, 1983.
  • Huang W-C, Ploth D.W., Bell D., Work J., Navar L.G. Bilateral renal function responses to converting enzyme inhibitor (SQ 20881) in two-kidney, one clip Goldblatt hypertensive rats. Hypertension 3:285–83, 1981.
  • Kappelgaard M., Damkjær Nielsen M., Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin. Chim. Acta 67:299–306, 1976.
  • Levens N.R., Peach M.J., Carey R.M. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ. Res. 48:157–67, 1981.
  • Navar L.G., Jirakulsomchok D., Bell P.D., Thomas C.E., Huang W-C. Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs. Hypertension 4:58–68, 1982.
  • Rasmussen S., Brahm M., Damkjær Nielsen M., Giese J., Larsen S., Brun C. Postpartum renal failure and malignant hypertension treated with captopril. Scand. J. Urol. Nephrol-17:209–12, 1983.
  • Wenting G.J., Tan-Tijong H.L., Derkx F.H.M., De Bruyn J.H.B., Man In't Veld, Schalckamp MADH. Split renal function after captopril in unilateral renal artery stenosis. Br. Med. J. 288:886–90, 1984.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.